Trial Profile
An Open Study for Steroid Resistant, Non-Thymectomized MG Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Mar 2014
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Myasthenia gravis
- Focus Registrational; Therapeutic Use
- Sponsors Astellas Pharma
- 30 Mar 2014 New trial record